Supraglottic carcinoma: Patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 4, 2002, Pages 948-958

  Johansen, Lars Vendelbo ^a   Grau, Cai ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Carcinoma; Laryngeal carcinoma; Prognosis; Radiation; Radiotherapy; Squamous cell carcinoma; Supraglottic carcinoma; Survival rate

Indexed keywords

DIAGNOSIS; PATIENT TREATMENT; SURGERY; TUMORS;

PARTIAL LARYNGECTOMY;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SECOND CANCER; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RECURRENCE; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037100056     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02840-7     Document Type: Article

References (45)

1. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group
2. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: An alternative to surgery
3. Conservative management of T1-T2N0 supraglottic cancer: A retrospective study
4. 331 cases of clinically node-negative supraglottic carcinoma of the larynx: A study of a modest size fixed field radiotherapy approach
5. Initial treatment of the early stages (I, II) of supraglottic squamous cell carcinoma: Partial laryngectomy versus radiotherapy
6. Recurrence after different primary treatment for cancer of the supraglottic larynx
7. Patterns of nodal metastasis and surgical management of the neck in supraglottic laryngeal carcinoma
8. Management of carcinoma of the supraglottic larynx: Evolution, current concepts, and future trends
9. Prognostic determinants in supraglottic carcinoma: Univariate and Cox regression analysis
10. Prognostic factors in supraglottic laryngeal carcinoma
11. Transoral carbon dioxide laser resection of supraglottic carcinoma
12. Endoscopic laser resection of supraglottic carcinoma
13. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
14. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer Phase III trial. EORTC Head and Neck Cancer Cooperative Group
15. Randomized trial of induction chemotherapy in larynx carcinoma
16. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer
17. Neoplasma Malignum Laryngis
18. Carcinoma Laryngis
19. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: Analysis of 478 patients treated from 1963 to 1985
20. Hypopharyngeal squamous cell carcinoma. Treatment results in 138 consecutively admitted patients
21. Squamous cell carcinoma of the oropharynx. An analysis of treatment results in 289 consecutive patients
22. Squamous cell carcinoma of the nasopharynx. An analysis of treatment results in 149 consecutive patients
23. Glottic carcinoma. Patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients
24. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study
25. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
26. Bleomycin, methotrexate and vincristine before irradiation of stage III and IV laryngeal and pharyngeal squamous cell carcinoma. A study initiated by the Danish Society of Head and Neck Cancer
27. Pharyngo-cutaneous fistulae after laryngectomy. Influence of previous radiotherapy and prophylactic metronidazole
28. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States
29. Commentary. Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy - Intergroup trial R91-11
30. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?
31. Treatment of the contralateral negative neck in supraglottic cancer patients with unilateral node metastases (N1-3)
32. Controversies in the treatment of N(0) neck in laryngeal cancer: Neck dissection, no surgery or sentinel lymph node biopsy?
33. Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx
34. The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae
35. The DAHANCA 6 and 7 trial. A randomized multicenter study of 5 versus 6 fractions per week of conventional radiotherapy of squamous cell carcinoma (SCC) of the head and neck
36. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
37. Second neoplasm in patients with head and neck cancer
38. Second malignant neoplasia in patients with T1 glottic cancer treated with radiation
39. Multiple primary malignant tumours in patients with head and neck cancer: The implications for follow-up
40. Second primary tumors in laryngeal cancer: Results of long-term follow-up
41. Second primary neoplasms in patients with laryngeal carcinoma